BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Biodexa Pharmaceuticals Plc
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 27, 2026
$0.39−0.07 (-14.36%)
Close on Oct 19, 2026
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 225.82B shares
Institutional holders
7
6 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Bigger Capital Fund, LP | 34,117,200 | – | 13G (passive) amendment | Sep 30, 2024 |
| Armistice Capital, LLC | 26,166 | 9.99% | 13G (passive) amendment | Jun 30, 2026 |
| Sabby Volatility Warrant Master Fund, Ltd. | 217,600 | 9.90% | 13G (passive) | Dec 31, 2025 |
| Steven Boyd | 187,975 | 9.99% | 13G (passive) amendment | Mar 31, 2026 |
| Brio Capital Management LLC | 167,681 | 9.00% | 13G (passive) amendment | Nov 14, 2024 |
| Mercer Street Global Opportunity Fund, LLC | 109,396,800 | 9.99% | 13G (passive) | Dec 21, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BDRX | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 14,809 | 0.00% | $43.09K | New | 0.00% |
| GAMMA Investing LLC | 1,203 | 0.00% | $3.50K | New | 0.00% |
| Allied Private Wealth LLC | 489 | 0.00% | $1.27K | New | 0.00% |
| SBI Securities Co., Ltd. | 29 | 0.00% | $84 | −122 | 0.00% |
| UBS Group AG | 25 | 0.00% | $73 | New | 0.00% |
| Hilton Head Capital Partners, LLC | 6 | 0.00% | $17 | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 5 | 0.00% | $15 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 7 | 0M | 0.0% | 6 / 0 | 1 / 0 | 0M | 0M |
| Q1 2026 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Fiona Mary Powell | Chief Financial Officer, Director | – | – | Mar 18, 2026 |
| Stephen Anthony Stamp | Chief Executive Officer, Director | – | – | Mar 18, 2026 |
| Stephen Barry Parker | Director | – | – | Mar 20, 2026 |
| Ann Louise Merchant | Director | – | – | Mar 18, 2026 |
| Simon Turton | Director | 2,765 | 0.00% | Mar 18, 2026 |
| Vries Simon de | Director | – | – | Mar 18, 2026 |